SOLENO THERAPEUTICS INC - Common Stock (SLNO) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2022 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
SLNO on Nasdaq
Shares outstanding
53,569,806
Price per share
$42.81
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
64,847,310
Total reported value
$3,002,891,552
% of total 13F portfolios
0.01%
Share change
-838,657
Value change
-$188,133,464
Number of holders
244
Price from insider filings
$42.81
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of SOLENO THERAPEUTICS INC - Common Stock (SLNO) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FMR LLC 15% +120% $678,796,830 +$389,571,468 7,833,778 +135% FMR LLC 31 Jul 2025
JANUS HENDERSON GROUP PLC 13% +18% $297,973,475 +$46,574,843 7,178,354 +19% JANUS HENDERSON GROUP PLC 31 Dec 2025
PRICE T ROWE ASSOCIATES INC /MD/ 6.9% +34% $299,939,842 +$91,911,561 3,461,510 +44% T. Rowe Price Associates, Inc. 30 Jun 2025
WELLINGTON MANAGEMENT GROUP LLP 6.2% $137,929,386 3,322,799 Wellington Management Group LLP 31 Dec 2025
Avoro Capital Advisors LLC 5.4% +32% $120,379,000 +$35,283,500 2,900,000 +41% Avoro Capital Advisors LLC 31 Dec 2025
VANGUARD GROUP INC 5.3% $189,763,272 2,807,149 The Vanguard Group 30 Sep 2025
ADAGE CAPITAL PARTNERS GP, L.L.C. 6.4% $204,422,873 2,775,976 Adage Capital Management, L.P. 31 Dec 2024
BlackRock, Inc. 5.5% +16% $231,754,330 +$63,374,124 2,766,225 +38% BlackRock, Inc. 30 Jun 2025
Vivo Opportunity Fund Holdings, L.P. 4.2% -46% $152,178,416 -$115,402,258 2,251,160 -43% Vivo Opportunity Fund Holdings, L.P. 30 Sep 2025
Adage Capital Management, L.P. 2.6% -64% $94,746,538 -$146,988,629 1,401,576 -61% Adage Capital Management, L.P. 30 Sep 2025
Nantahala Capital Management, LLC 2% -60% $86,766,978 -$140,918,982 1,001,350 -62% Nantahala Capital Management, LLC 30 Jun 2025

As of 31 Dec 2025, 244 institutional investors reported holding 64,847,310 shares of SOLENO THERAPEUTICS INC - Common Stock (SLNO). This represents 121% of the company’s total 53,569,806 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of SOLENO THERAPEUTICS INC - Common Stock (SLNO) together control 94% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
FMR LLC 15% 8,079,304 +1% 0.02% $374,071,758
JANUS HENDERSON GROUP PLC 13% 7,178,354 +19% 0.15% $332,302,144
BlackRock, Inc. 7.2% 3,871,639 +11% 0% $179,256,886
WELLINGTON MANAGEMENT GROUP LLP 6.2% 3,322,799 +44% 0.03% $153,845,595
PRICE T ROWE ASSOCIATES INC /MD/ 6.2% 3,318,698 -15% 0.02% $153,657,000
VANGUARD GROUP INC 5.7% 3,060,361 +9% 0% $141,694,714
Avoro Capital Advisors LLC 5.4% 2,900,000 +13% 1.3% $134,270,000
STATE STREET CORP 4.9% 2,649,626 +22% 0% $122,677,684
Nantahala Capital Management, LLC 2.5% 1,314,002 +52% 3.6% $60,838,293
MILLENNIUM MANAGEMENT LLC 2.3% 1,236,321 +26% 0.04% $57,241,662
Commodore Capital LP 2.2% 1,200,000 -11% 3.7% $55,560,000
BRAIDWELL LP 2.2% 1,187,859 -7.3% 1.8% $54,997,872
GEODE CAPITAL MANAGEMENT, LLC 2.2% 1,163,338 +7.2% 0% $53,870,660
Polar Capital Holdings Plc 2.1% 1,136,929 -4.5% 0.24% $52,639,813
Woodline Partners LP 2.1% 1,111,778 +311% 0.2% $51,475,321
Deep Track Capital, LP 1.9% 1,000,000 1.1% $46,300,000
GOLDMAN SACHS GROUP INC 1.7% 913,050 +64% 0.01% $42,274,215
Vivo Capital, LLC 1.7% 894,909 -61% 2.7% $41,434,287
Invesco Ltd. 1.6% 875,019 -42% 0.01% $40,513,380
READYSTATE ASSET MANAGEMENT LP 1.6% 874,447 +325% 1.8% $40,486,896
FRANKLIN RESOURCES INC 1.5% 823,958 -1.4% 0.01% $38,149,268
Pictet Asset Management Holding SA 1.2% 624,128 +13% 0.03% $28,897,126
Bank of New York Mellon Corp 1.2% 621,811 -0.86% 0.01% $28,789,839
Hood River Capital Management LLC 1.2% 618,005 +0.75% 0.31% $28,613,632
Artia Global Partners LP 1% 533,698 -21% 4% $24,710,217

Institutional Holders of SOLENO THERAPEUTICS INC - Common Stock (SLNO) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 64,847,310 $3,002,891,552 -$188,133,464 $46.30 244
2025 Q3 65,165,847 $4,403,391,909 +$507,196,048 $67.60 237
2025 Q2 56,749,470 $4,754,316,405 +$213,454,357 $83.78 231
2025 Q1 54,568,286 $3,901,554,193 +$304,734,926 $71.45 215
2024 Q4 51,039,620 $2,293,782,533 +$169,954,638 $44.95 164
2024 Q3 47,119,847 $2,378,750,710 +$200,292,187 $50.49 140
2024 Q2 43,315,547 $1,767,618,917 +$339,170,617 $40.80 112
2024 Q1 34,986,278 $1,496,099,214 +$153,335,358 $42.80 97
2023 Q4 31,409,972 $1,264,282,488 +$428,860,586 $40.25 76
2023 Q3 20,301,195 $598,794,549 +$451,363,927 $29.51 54
2023 Q2 4,852,710 $20,757,863 +$7,837,293 $4.29 22
2023 Q1 3,071,637 $6,538,076 +$3,161,387 $2.14 20
2022 Q4 2,785,956 $5,517,109 +$81,616 $1.98 22
2022 Q3 2,781,988 $4,645,586 +$4,630,000 $1.67 14